Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues

AIDS

Volumn 11, Issue 2, 1997, Pages 185-190

  Famularo, Giuseppe ^a,d,e   Moretti, Sonia ^a   Marcellini, Sonia ^a   Trinchieri, Vito ^a,b   Tzantzoglou, Sonia ^a,b   Santini, Gino ^a   Longo, Antonio ^c   De Simone, Claudio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Sigma Tau SpA   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e Infectious Diseases   (Italy)

Author keywords

Acetyl carnitine; Axonal peripheral neuropathy; Didanosine; Stavudine; Zalcitabine; Zidovudine

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIRETROVIRUS AGENT; CARNITINE DERIVATIVE; DIDANOSINE; MITOCHONDRIAL DNA; NUCLEOSIDE ANALOG; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD LEVEL; CARNITINE DEFICIENCY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ACETYLCARNITINE; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; AXONS; CROSS-SECTIONAL STUDIES; DIDANOSINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; ZALCITABINE;

EID: 0031032991     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199702000-00008     Document Type: Article

References (29)

1. Simpson DM, Tagliati M: Neurologic manifestations of HIV infection. Ann Intern Med 1494, 121:769-785.
2. Faulds D, Brogden RN: Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection. Drugs 1992, 44:94-116.
3. Whittington R, Brogden RN: Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS). Drugs 1992, 44: 656-683.
4. Browne MJ, Mayer KH, Chafee SB, et al.: 2′, 3′-didehydro-3′-deoxythymidine (d4T) in patients with AIDS or AIDS related complex: a phase I trial. J Infect Dis 1993, 167:21-29.
5. Chen CH, Vasquez-Padua M, Cheng YC: Effect of anti-human immunodeficiency virus nucleoside analogs on mitochrondrial DNA and its implication for delayed toxicity. Mol Pharmacol 1991, 39:625-628.
6. Lewis W, Dalakas MC: Mitochondrial toxicity of antiviral drugs. Nature Med 1995, 1:417-422.
7. Bremer J: The role of carnitine in intracellular metabolism J Clin Chem Clin Biochem 1990, 28:297-301.
8. Colucci WJ, Gandour RD: Carnitine acetyltransferase: a review of its biology, enzymology, and bioorganic chemistry. Bioorg Chem 1988, 16:307-334.
9. Pettorossi VE, Brunetti V, Carrobi C, Della Torre G, Grassi S: L-acetylcarnitine enhances functional muscle reinnervation. Drugs Exp Clin Res 1991, 17:119-125.
10. Rampello L, Giammona G, Aleppo G, Favit A, Fiore L: Trophic action of acetyl-L-carnitine in neuronal cultures. Acta Neurol 1992, 14:15-21.
11. Forloni G, Angerelti N, Smiroldo S: Neuroprotective activity of acetyl-L-carnitine: studies in vitro. J Neurosci Res 1994, 37:92-96.
12. Rosenthal RE, Williams R, Bogaert YL, Getson PR, Fiskum G: Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetylcarnitine. Stroke 1992, 23:1312-1317.
13. De Angelis C, Scarfo C, Falcinelli M, Reda E, Ramacci MT, Angelucci L: Levocarnitine acetyl stimulates peripheral nerve regeneration and neuromuscular junction remodelling following sciatic nerve injury. Int J Clin Pharmacol Res 1992, 12:269-279.
14. Tenconi B, Donadoni L, Germani E, et al.: Intraspinal degenerative atrophy caused by sciatic nerve lesions prevented by acetyl-L-carnitine. Int J Clin Pharmacol Res 1942, 12:263-267.
15. Piovesan P, Pacitici L, Taglialatela G, Ramacci MT, Angelucci L: Acetylcarnitine treatment increases choline acetyltransferase activity and NGF levels in the CNS of adult rats following total fimbria fornix transection. Brain Res 1994, 633:77-82.
16. De Simone R, Ramacci MT, Aloe L: Effect of acetyl-L-carnitine on forebrain cholinergic neurons of developing rats. Int J Dev Neurosci 1991, 9:39-46.
17. Taglialatela G, Angelucci L, Ramacci MT, Werrbach Perez K, Jackson GR, Perez Polo JR: Stimulation of nerve growth factor receptors in PC12 cells by acetyl-L-carnitine. Biochem Pharmacol 1992, 44:577-585.
18. Taglialatela G, Navarra D, Cruciani R, Ramacci MT, Alema GS Angelucci L: Acetyl-L-carnitine increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats. Exp Gerontol 1994, 29:55-56.
19. Castorina M, Ferraris L: Acetyl-L-carnitine affects aged brain receptorial system in rodents. Life Sci 1994, 54:1205-1214.
20. Gadaleta MN, Petruzzella V, Renis M, et al.: Reduced transcription of mitochondrial DNA in the senescent rat. Tissue dependence and effect of L-carnitine. Eur J Biochem 1990, 187:501-506.
21. Villa RF, Turpenoja L, Benzi G, et al.: Action of L-acetylcarnitine on age-dependent modifications of mitochondrial membrane proteins from rat cerebellum. Neurochem Res 1988, 13:509-516.
22. Villa RF, Gorini A: Action of L-acetylcarnitine on different cerebral mitocbondrial populations from hippocampus and striatum during aging. Neurochem Res 1991, 16:1125-1132.
23. Cornblath DR, McArthur JC: Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988, 38:794-796.
24. De Simone C, Tzantzoglou S, Jirillo E, Marzo A, Vullo V, Arrigoni Martelli B: L-carnitine deficiency in AIDS patients. AIDS 1992, 6:203-205.
25. De Simone C, Famularo G, Tzantzoglou S, Trinchieri V, Moretti S, Sorice F: Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: effect of oral L-carnitine. AIDS 1994, 8:655-660.
26. Editorial: Carnitine deficiency. Lancet 1990, 335:631-633.
27. Famularo G, De Simone C: A new era for carnitine? Immunol Today 1995, 16:211-213.
28. Dalakas MC, Leon-Monzon ME, Bernardini I, Gahl WA: The AZT-induced myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol 1994, 35:482-487.
29. Semino-Mora MC, Leon-Monzon ME, Dalakas MC: Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro. Lab Invest 1994, 71:102-112.